These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6142428)

  • 1. Neurobiological mechanisms in human anxiety. Evidence supporting central noradrenergic hyperactivity.
    Charney DS; Redmond DE
    Neuropharmacology; 1983 Dec; 22(12B):1531-6. PubMed ID: 6142428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies.
    Bremner JD; Krystal JH; Southwick SM; Charney DS
    Synapse; 1996 May; 23(1):28-38. PubMed ID: 8723133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.
    Charney DS; Redmond DE; Galloway MP; Kleber HD; Heninger GR; Murberg M; Roth RH
    Life Sci; 1984 Sep; 35(12):1263-72. PubMed ID: 6482651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine withdrawal: activation of brain noradrenergic neurons with specifically reduced alpha 2-receptor sensitivity.
    Engberg G; Elam M; Svensson TH
    Life Sci; 1982 Jan; 30(3):235-43. PubMed ID: 6280003
    [No Abstract]   [Full Text] [Related]  

  • 5. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
    Roth RH; Elsworth JD; Redmond DE
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
    Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
    Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity.
    Sanghera MK; McMillen BA; German DC
    Eur J Pharmacol; 1982 Dec; 86(1):107-10. PubMed ID: 6130954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety.
    Redmond DE; Huang YH
    Life Sci; 1979 Dec; 25(26):2149-62. PubMed ID: 120478
    [No Abstract]   [Full Text] [Related]  

  • 9. The primate locus coeruleus and effects of clonidine on opiate withdrawal.
    Redmond DE; Huang YH
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):25-9. PubMed ID: 6282817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal.
    Crawley JN; Laverty R; Roth RH
    Eur J Pharmacol; 1979 Aug; 57(2-3):247-50. PubMed ID: 573692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic function in panic disorder.
    Charney DS; Woods SW; Nagy LM; Southwick SM; Krystal JH; Heninger GR
    J Clin Psychiatry; 1990 Dec; 51 Suppl A():5-11. PubMed ID: 2258377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine.
    Britton KT; Svensson T; Schwartz J; Bloom FE; Koob GF
    Life Sci; 1984 Jan; 34(2):133-9. PubMed ID: 6537983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission.
    Dennis T; Curet O; Nishikawa T; Scatton B
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):225-34. PubMed ID: 3003590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Agren H
    Acta Psychiatr Scand Suppl; 1986; 327():91-113. PubMed ID: 3529831
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical aspects of anxiety].
    Boulenger JP; Uhde TW
    Sem Hop; 1982 Dec; 58(44):2573-9. PubMed ID: 6130605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
    Crespi F
    J Neurosci Methods; 2009 May; 180(1):97-105. PubMed ID: 19427535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the involvement of presynaptic alpha-2 adrenoceptors in the regulation of norepinephrine metabolism in the rat brain.
    Curet O; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1987 Jan; 240(1):327-36. PubMed ID: 3027307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemistry of anxiety.
    Haefely W
    Ann Acad Med Singap; 1985 Jan; 14(1):81-3. PubMed ID: 2988406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine.
    Esposito E; Kruszewska A; Ossowska G; Samanin R
    Psychopharmacology (Berl); 1987; 93(3):393-6. PubMed ID: 3124170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.